Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN

Luca Scarallo, Paolo Lionetti, Jaroslaw Kierkus, Lauren Collen, Victoria Riedl, Christian Jakobsen, Gemma Pujol‐Muncunill, Kaija‐Leena Kolho, Marta Velasco Rodriguez‐Belvis, Katarina Mitrova, Darja Urlep, Benedicte Pigneur, Seamus Hussey, Firas Rinawi, Jan De Laffolie, Karl Mårild, Anat Yerushalmy‐Feler, Raffi Lev Tzion, Maya Granot, Marina Aloi, Elisabeth De Greef, Christos Tzvinikos, Christoph Norden, Caterina Strisciuglio, Kwang Yang Lee, Rémi Duclaux‐Loras, Saverio Pochesci, Naire Sansotta, Pejman Rohani, Dror S. Shouval, Yael Weintraub, Unknown

Open source

DOI: 10.1002/jpn3.70645
Published: 2026-11-05
Container: Journal of Pediatric Gastroenterology and Nutrition
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jpn3.70645,
  title = {Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN},
  author = {Luca Scarallo and Paolo Lionetti and Jaroslaw Kierkus and Lauren Collen and Victoria Riedl and Christian Jakobsen and Gemma Pujol‐Muncunill and Kaija‐Leena Kolho and Marta Velasco Rodriguez‐Belvis and Katarina Mitrova and Darja Urlep and Benedicte Pigneur and Seamus Hussey and Firas Rinawi and Jan De Laffolie and Karl Mårild and Anat Yerushalmy‐Feler and Raffi Lev Tzion and Maya Granot and Marina Aloi and Elisabeth De Greef and Christos Tzvinikos and Christoph Norden and Caterina Strisciuglio and Kwang Yang Lee and Rémi Duclaux‐Loras and Saverio Pochesci and Naire Sansotta and Pejman Rohani and Dror S. Shouval and Yael Weintraub and Unknown},
  year = {2026},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  doi = {10.1002/jpn3.70645},
  url = {https://doi.org/10.1002/jpn3.70645}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN
AU  - Luca Scarallo
AU  - Paolo Lionetti
AU  - Jaroslaw Kierkus
AU  - Lauren Collen
AU  - Victoria Riedl
AU  - Christian Jakobsen
AU  - Gemma Pujol‐Muncunill
AU  - Kaija‐Leena Kolho
AU  - Marta Velasco Rodriguez‐Belvis
AU  - Katarina Mitrova
AU  - Darja Urlep
AU  - Benedicte Pigneur
AU  - Seamus Hussey
AU  - Firas Rinawi
AU  - Jan De Laffolie
AU  - Karl Mårild
AU  - Anat Yerushalmy‐Feler
AU  - Raffi Lev Tzion
AU  - Maya Granot
AU  - Marina Aloi
AU  - Elisabeth De Greef
AU  - Christos Tzvinikos
AU  - Christoph Norden
AU  - Caterina Strisciuglio
AU  - Kwang Yang Lee
AU  - Rémi Duclaux‐Loras
AU  - Saverio Pochesci
AU  - Naire Sansotta
AU  - Pejman Rohani
AU  - Dror S. Shouval
AU  - Yael Weintraub
AU  - Unknown
PY  - 2026
JO  - Journal of Pediatric Gastroenterology and Nutrition
DO  - 10.1002/jpn3.70645
UR  - https://doi.org/10.1002/jpn3.70645
ER  -

APA

Scarallo, L., Lionetti, P., Kierkus, J., Collen, L., Riedl, V., Jakobsen, C., Pujol‐Muncunill, G., Kolho, K., Rodriguez‐Belvis, M. V., Mitrova, K., Urlep, D., Pigneur, B., Hussey, S., Rinawi, F., Laffolie, J. D., Mårild, K., Yerushalmy‐Feler, A., Tzion, R. L., Granot, M., Aloi, M., Greef, E. D., Tzvinikos, C., Norden, C., Strisciuglio, C., Lee, K. Y., Duclaux‐Loras, R., Pochesci, S., Sansotta, N., Rohani, P., Shouval, D. S., Weintraub, Y., & Unknown (2026). Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70645

Source records

crossref · retrieved 2026-11-08T07:21:12.318Z